Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 17 | 2024 | 3224 | 2.270 |
Why?
|
| Pulmonary Emphysema | 8 | 2021 | 688 | 1.740 |
Why?
|
| Thorax | 2 | 2023 | 553 | 0.750 |
Why?
|
| Pulmonary Artery | 3 | 2024 | 1921 | 0.710 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2019 | 1126 | 0.700 |
Why?
|
| Lung | 9 | 2023 | 9994 | 0.610 |
Why?
|
| P-Selectin | 1 | 2019 | 599 | 0.560 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 691 | 0.560 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2024 | 20509 | 0.530 |
Why?
|
| Emphysema | 1 | 2017 | 240 | 0.490 |
Why?
|
| Air Pollution | 4 | 2019 | 2317 | 0.480 |
Why?
|
| Auditory Perception | 1 | 2019 | 580 | 0.460 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2017 | 1031 | 0.450 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2024 | 911 | 0.400 |
Why?
|
| Atherosclerosis | 3 | 2019 | 3517 | 0.380 |
Why?
|
| Respiratory Function Tests | 5 | 2021 | 1683 | 0.380 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 867 | 0.370 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1523 | 0.350 |
Why?
|
| Air Pollutants | 3 | 2019 | 2844 | 0.350 |
Why?
|
| Pulmonary Heart Disease | 1 | 2019 | 34 | 0.340 |
Why?
|
| Spirometry | 4 | 2023 | 924 | 0.340 |
Why?
|
| Particulate Matter | 4 | 2019 | 2559 | 0.330 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4433 | 0.320 |
Why?
|
| Heart Ventricles | 4 | 2020 | 3811 | 0.250 |
Why?
|
| Vital Capacity | 3 | 2019 | 965 | 0.240 |
Why?
|
| Disease Progression | 7 | 2021 | 13502 | 0.210 |
Why?
|
| E-Selectin | 1 | 2014 | 576 | 0.200 |
Why?
|
| Mucus | 1 | 2024 | 342 | 0.200 |
Why?
|
| Bronchiectasis | 1 | 2023 | 139 | 0.200 |
Why?
|
| Aspirin | 2 | 2018 | 3364 | 0.190 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2019 | 974 | 0.180 |
Why?
|
| Asthma | 1 | 2019 | 6172 | 0.170 |
Why?
|
| Nitrogen Oxides | 2 | 2019 | 128 | 0.160 |
Why?
|
| Auscultation | 1 | 2019 | 38 | 0.160 |
Why?
|
| Environmental Exposure | 3 | 2019 | 4412 | 0.150 |
Why?
|
| Thrombocytosis | 1 | 2018 | 82 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1830 | 0.140 |
Why?
|
| Angiotensins | 1 | 2017 | 143 | 0.140 |
Why?
|
| Middle Aged | 20 | 2024 | 220352 | 0.140 |
Why?
|
| Linear Models | 4 | 2019 | 5877 | 0.140 |
Why?
|
| Ventricular Function, Right | 1 | 2010 | 610 | 0.130 |
Why?
|
| Aged, 80 and over | 9 | 2019 | 58995 | 0.130 |
Why?
|
| Ozone | 2 | 2019 | 477 | 0.130 |
Why?
|
| Forced Expiratory Volume | 3 | 2023 | 1809 | 0.130 |
Why?
|
| Carbon | 2 | 2019 | 669 | 0.130 |
Why?
|
| Exercise Tolerance | 3 | 2024 | 830 | 0.120 |
Why?
|
| Tomography | 1 | 2017 | 411 | 0.120 |
Why?
|
| Aged | 16 | 2024 | 169152 | 0.120 |
Why?
|
| Humans | 28 | 2024 | 760621 | 0.120 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 14495 | 0.120 |
Why?
|
| Sleep | 1 | 2019 | 4751 | 0.110 |
Why?
|
| Male | 19 | 2024 | 359744 | 0.100 |
Why?
|
| Exercise | 2 | 2016 | 5787 | 0.100 |
Why?
|
| Female | 20 | 2024 | 391270 | 0.100 |
Why?
|
| Smoking | 4 | 2023 | 9073 | 0.100 |
Why?
|
| Prospective Studies | 7 | 2023 | 54303 | 0.100 |
Why?
|
| Organ Size | 2 | 2019 | 2254 | 0.090 |
Why?
|
| Motor Activity | 1 | 2010 | 2687 | 0.090 |
Why?
|
| United States | 8 | 2021 | 72461 | 0.090 |
Why?
|
| Dyspnea | 1 | 2017 | 1352 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 3527 | 0.080 |
Why?
|
| Cohort Studies | 6 | 2024 | 41335 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2017 | 6360 | 0.070 |
Why?
|
| Respiratory System | 1 | 2019 | 557 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2017 | 364 | 0.060 |
Why?
|
| Genotype | 1 | 2019 | 12960 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 12159 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15840 | 0.050 |
Why?
|
| Actigraphy | 1 | 2016 | 518 | 0.050 |
Why?
|
| Polysomnography | 1 | 2019 | 1825 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2022 | 12531 | 0.050 |
Why?
|
| Parasympathectomy | 1 | 2020 | 3 | 0.050 |
Why?
|
| Mucociliary Clearance | 1 | 2020 | 80 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2022 | 469 | 0.040 |
Why?
|
| Incidence | 2 | 2019 | 21392 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10756 | 0.040 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2020 | 113 | 0.040 |
Why?
|
| Hospitalization | 1 | 2019 | 10790 | 0.040 |
Why?
|
| Endophenotypes | 1 | 2020 | 255 | 0.040 |
Why?
|
| Mortality | 1 | 2019 | 2916 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2020 | 409 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2020 | 782 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 441 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39261 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 686 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2020 | 732 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 2128 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10827 | 0.030 |
Why?
|
| Disease | 1 | 2020 | 671 | 0.030 |
Why?
|
| Cause of Death | 1 | 2024 | 3725 | 0.030 |
Why?
|
| Air Pollution, Indoor | 1 | 2020 | 893 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2016 | 5523 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 219994 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 7408 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2020 | 1634 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2145 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2557 | 0.020 |
Why?
|
| Pneumonia | 1 | 2020 | 2131 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3663 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2020 | 3047 | 0.020 |
Why?
|
| Neutrophils | 1 | 2020 | 3767 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 29658 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 6659 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10547 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 3201 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8056 | 0.020 |
Why?
|
| Comorbidity | 1 | 2018 | 10551 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 36290 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 80372 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 15757 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17790 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 25942 | 0.010 |
Why?
|
Concepts
(112)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_